PRP was prepared by refrigerating a total of 8 ml of blood taken from the patient autologously into a sterile
citrated PRP tube. After centrifuging at +4 degrees Celsius, 2500 rpm, and 8 minutes, the lower 1/3 of the
plasma formed in the tube was withdrawn into a 2.5 ml injector, totaling 1 ml of PRP. 0.5 ml of Erythropoietin
was added to the syringe containing 1 ml of citrated PRP. A total of 1.5 ml of citrate, PRP and Erythropoietin
mixture was injected into the right subtenon space under topical anesthesia. Immediately after the
subtenon injection, the patient was fitted with a MagnovisionTM electromagnetic iontophoresis helmet.
Magnovision is a stimulator and iontophoresis device specifically designed for retina/optic nerve diseases,
which contains 9 coils and generates a 2000 mG magnetic field with a 42 Hertz vibration frequency that
synchronously stimulates the bulbus, visual pathways and occipital cortex. These parameters are fixed
values by the manufacturer that cannot be changed for patient safety. Each session is applied effectively
and safely for 30 minutes. This process is repeated for 3 sessions in 2 months between 3 or 4 weeks interval.
